Relation unveils MORGAN, the next-generation model of cellular biology
Press releases July 30, 2026
“
“The future of drug discovery depends on our ability to understand how human cells respond to disease and treatment at an unprecedented level of detail,” said David Roblin, M.D., Chief Executive Officer, Relation. “MORGAN represents a major step toward that future. By combining frontier AI with industrial-scale generation of high-quality multi-omic perturbation data, we're building cellular foundation models that can help reveal disease mechanisms, identify new therapeutic targets and accelerate the discovery of better medicines. This is the scientific infrastructure we believe will power the next generation of drug discovery.”